Federation des caisses Desjardins du Quebec’s Serina Therapeutics SER Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2	Buy	+1	New	+$2	﹤0.01%	2961
2019 Q1	–	Sell	-9	Closed	-$897	–	2136
2018 Q4	$897	Buy	+9	New	+$1.14K	﹤0.01%	1965

Other funds holding SER

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

AWE

Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SER Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Serina Therapeutics (SER) in Q1 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #2961 among its holdings. This is a return to the name: Federation des caisses Desjardins du Quebec previously reported a position in SER as recently as Q4 2018.

Federation des caisses Desjardins du Quebec first reported a position in SER in Q4 2018 and has held it in 2 quarters since. The position peaked at $897 in Q4 2018. 25 funds tracked by Wall St. Rank hold SER as of Q1 2026.

Federation des caisses Desjardins du Quebec held 1 share of Serina Therapeutics worth $2 as of Q1 2026.
Serina Therapeutics was a new Federation des caisses Desjardins du Quebec position in Q1 2026.
Serina Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2961 holding.
Federation des caisses Desjardins du Quebec first reported a position in Serina Therapeutics in Q4 2018 and has held it in 2 quarters since.
Federation des caisses Desjardins du Quebec's Serina Therapeutics position peaked at $897 in Q4 2018.
25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.